Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | NXP800 |
Synonyms | |
Therapy Description |
NXP800 is an inhibitor of the HSF1 pathway, with potential antitumor activity (Cancer Res 2022;82(12_Suppl):Abstract nr ND08). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NXP800 | NXP-800|NXP 800 | NXP800 is an inhibitor of the HSF1 pathway, with potential antitumor activity (Cancer Res 2022;82(12_Suppl):Abstract nr ND08). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05226507 | Phase I | NXP800 | A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers | Recruiting | USA | GBR | 0 |